All-Weather Media

Admin

Report: ECB officials say the rate-cut cycle is likely over.

Report: ECB officials say the rate-cut cycle is likely over.

On Thursday, according to media reports citing informed sources, based on the latest assessment of economic growth and inflation prospects, European Central Bank officials expect that the current interest rate cut cycle is most likely over. Unless another major external shock occurs, after eight consecutive rate cuts from the peak

Federal Reserve chairman frontrunner Hassett: The CPI report is shockingly good, and the Fed has ample room to cut rates.

Federal Reserve chairman frontrunner Hassett: The CPI report is shockingly good, and the Fed has ample room to cut rates.

White House economic adviser Kevin Hassett welcomed the newly released Consumer Price Index (CPI) report on Thursday, saying the U.S. economy is showing high growth and low inflation. In an interview, he stated: I'm not saying we've already declared victory on the issue of prices,

Trump’s executive order lowers marijuana's regulatory classification; investors "sell the news," marijuana stocks fall broadly.

Trump’s executive order lowers marijuana's regulatory classification; investors "sell the news," marijuana stocks fall broadly.

``` On Thursday, U.S. President Trump downgraded marijuana from the strictest category of controlled substances, easing restrictions but not fully legalizing it. According to the executive order, marijuana will be downgraded from a Schedule I controlled substance to Schedule III, placing it in the same category as ketamine. However, senior

U.S. CPI cools down, but don’t celebrate too soon: Economists suspect government shutdown distorted the data, some point out obvious errors.

U.S. CPI cools down, but don’t celebrate too soon: Economists suspect government shutdown distorted the data, some point out obvious errors.

The official US data released shows that core inflation for November unexpectedly fell to the lowest level in more than four years. However, this seemingly positive signal is being widely questioned by economists, because a record-long government shutdown hindered data collection efforts, significantly undermining the credibility of the inflation report.

Lagarde hints ECB is in no rush to act: policy is in a favorable position, no preset rate path, all options should be considered.

Lagarde hints ECB is in no rush to act: policy is in a favorable position, no preset rate path, all options should be considered.

``` After the European Central Bank kept interest rates unchanged for the fourth consecutive meeting and raised economic growth forecasts for this year and the next three years, ECB President Lagarde reiterated that the central bank is in a "favorable position" regarding interest rate policy. This statement aims to

Private Placement Proxy “Maze”: 150,000 Yuan “Friendship Investment” Breached Net Asset Value

Private Placement Proxy “Maze”: 150,000 Yuan “Friendship Investment” Breached Net Asset Value

It is not unusual for private fund employees to buy their own company's products. According to industry rules, internal personnel at private fund institutions participating in their own fund investments are often not subject to the minimum investment threshold of one million yuan. This is originally an internal

Eli Lilly’s blockbuster oral weight-loss drug trial achieves new progress: After switching from injection to oral form, effective weight loss is maintained, and a marketing application has been submitted to the FDA.

Eli Lilly’s blockbuster oral weight-loss drug trial achieves new progress: After switching from injection to oral form, effective weight loss is maintained, and a marketing application has been submitted to the FDA.

Eli Lilly’s investigational oral weight-loss drug orforglipron has achieved a key milestone in its latest late-stage clinical trial, demonstrating that it can effectively help patients switching from injectables to maintain their weight-loss results. Given the drug’s clinical potential, Lilly announced Thursday that it has submitted a New Drug